MetaVia Inc

MTVANASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

6.58M

on 2026-06-30, from 446K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-11 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

S-3 of 2024-04-12. Not read yet. S-3 ↗

$2.3M

Ladenburg Thalmann, agreement of 2026-07-02. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

8.96M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

3.2 quarters

$12.6M on 2026-06-30 ÷ $4.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-01-15	Public offering	not read	$3.10	$8.1M	424B4 ↗
2025-05-08	Private placement incl. 4.61M pre-funded	9,210,324	$0.71	not stated	8-K ↗

Also on file: a 1-for-11 reverse split, 2025-12-05 8-K ↗